Cargando…
Five-Year Retrospective Analysis of Eurosilicone’s Silicone Gel–Filled Breast Implants
BACKGROUND: Silicone breast implants have been widely used for breast augmentation and reconstruction. During this time, silicone breast implants have undergone several modifications to improve their safety, quality, and clinical performance. Complications such as reoperation, capsular contracture,...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671275/ https://www.ncbi.nlm.nih.gov/pubmed/33791613 http://dx.doi.org/10.1093/asjof/ojz018 |
_version_ | 1783610898873581568 |
---|---|
author | Saturno, Maurizio Stewart, Sharon Bell, Erin Esposito, Emanuela |
author_facet | Saturno, Maurizio Stewart, Sharon Bell, Erin Esposito, Emanuela |
author_sort | Saturno, Maurizio |
collection | PubMed |
description | BACKGROUND: Silicone breast implants have been widely used for breast augmentation and reconstruction. During this time, silicone breast implants have undergone several modifications to improve their safety, quality, and clinical performance. Complications such as reoperation, capsular contracture, and rupture are risks often associated with breast implants. OBJECTIVES: The authors conducted a retrospective study to analyze and report complication rates associated with Eurosilicone’s (Eurosilicone S.A.S, Apt, Cedex, France) silicone gel–filled breast implants over a period of 5 years. METHODS: In this retrospective clinical study, 2151 women who underwent either breast augmentation or breast reconstruction with Eurosilicone breast implants were diagnosed. Data on early and late complications including implant removal (explantation/exchange), capsular contracture, and rupture were collected using questionnaires, completed by 39 surgeons across Italy. RESULTS: Of the 2151, only 60 patients (2.78%) required implant removal. Twenty-five patients experienced capsular contracture (Baker Grade III/IV), giving an actual rate of 1.2%. The actual rate of implant rupture confirmed by breast magnetic resonance images was 0.18% (4 implants). Six patients (0.27%) were diagnosed with breast cancer following breast augmentation, and local complications including hematoma (1 patient) and seroma (2 patients) were experienced. CONCLUSIONS: This retrospective clinical study involving Eurosilicone’s round and anatomical textured silicone gel–filled mammary implants demonstrates an excellent safety profile through 5 years. Level of Evidence: 2 [Image: see text] |
format | Online Article Text |
id | pubmed-7671275 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-76712752021-03-30 Five-Year Retrospective Analysis of Eurosilicone’s Silicone Gel–Filled Breast Implants Saturno, Maurizio Stewart, Sharon Bell, Erin Esposito, Emanuela Aesthet Surg J Open Forum Original Article BACKGROUND: Silicone breast implants have been widely used for breast augmentation and reconstruction. During this time, silicone breast implants have undergone several modifications to improve their safety, quality, and clinical performance. Complications such as reoperation, capsular contracture, and rupture are risks often associated with breast implants. OBJECTIVES: The authors conducted a retrospective study to analyze and report complication rates associated with Eurosilicone’s (Eurosilicone S.A.S, Apt, Cedex, France) silicone gel–filled breast implants over a period of 5 years. METHODS: In this retrospective clinical study, 2151 women who underwent either breast augmentation or breast reconstruction with Eurosilicone breast implants were diagnosed. Data on early and late complications including implant removal (explantation/exchange), capsular contracture, and rupture were collected using questionnaires, completed by 39 surgeons across Italy. RESULTS: Of the 2151, only 60 patients (2.78%) required implant removal. Twenty-five patients experienced capsular contracture (Baker Grade III/IV), giving an actual rate of 1.2%. The actual rate of implant rupture confirmed by breast magnetic resonance images was 0.18% (4 implants). Six patients (0.27%) were diagnosed with breast cancer following breast augmentation, and local complications including hematoma (1 patient) and seroma (2 patients) were experienced. CONCLUSIONS: This retrospective clinical study involving Eurosilicone’s round and anatomical textured silicone gel–filled mammary implants demonstrates an excellent safety profile through 5 years. Level of Evidence: 2 [Image: see text] Oxford University Press 2019-06-20 /pmc/articles/PMC7671275/ /pubmed/33791613 http://dx.doi.org/10.1093/asjof/ojz018 Text en © 2019 The American Society for Aesthetic Plastic Surgery, Inc. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Saturno, Maurizio Stewart, Sharon Bell, Erin Esposito, Emanuela Five-Year Retrospective Analysis of Eurosilicone’s Silicone Gel–Filled Breast Implants |
title | Five-Year Retrospective Analysis of Eurosilicone’s Silicone Gel–Filled Breast Implants |
title_full | Five-Year Retrospective Analysis of Eurosilicone’s Silicone Gel–Filled Breast Implants |
title_fullStr | Five-Year Retrospective Analysis of Eurosilicone’s Silicone Gel–Filled Breast Implants |
title_full_unstemmed | Five-Year Retrospective Analysis of Eurosilicone’s Silicone Gel–Filled Breast Implants |
title_short | Five-Year Retrospective Analysis of Eurosilicone’s Silicone Gel–Filled Breast Implants |
title_sort | five-year retrospective analysis of eurosilicone’s silicone gel–filled breast implants |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671275/ https://www.ncbi.nlm.nih.gov/pubmed/33791613 http://dx.doi.org/10.1093/asjof/ojz018 |
work_keys_str_mv | AT saturnomaurizio fiveyearretrospectiveanalysisofeurosiliconessiliconegelfilledbreastimplants AT stewartsharon fiveyearretrospectiveanalysisofeurosiliconessiliconegelfilledbreastimplants AT bellerin fiveyearretrospectiveanalysisofeurosiliconessiliconegelfilledbreastimplants AT espositoemanuela fiveyearretrospectiveanalysisofeurosiliconessiliconegelfilledbreastimplants |